THC · Tenet Healthcare Corporation
$243.36
+7.92% last session
End-of-day data · updated 2026-07-29
Market cap
$23B
Enterprise value
$37B
Trailing P/E
10.2
Forward P/E
12.8
Dividend yield
—
Beta
1.27
Avg volume
2M
Employees
77K
2D change
7.92%
5D change
—
10D change
34.74%
30D change
40.32%
60D change
49.80%
MTD change
37.36%
YTD change
32.16%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — THC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-28
Latest call per bank · past 12 months
UBS
Buy$308
+26.6% vs priceMorgan Stanley
Overweight$274
+12.6% vs priceRBC Capital
Outperform$283
+16.3% vs priceBarclays
Overweight$271
+11.4% vs priceWells Fargo
Overweight$231
-5.1% vs priceJefferies
Buy$265
+8.9% vs priceJP Morgan
Overweight$230
-5.5% vs priceBank of America
Buy$225
-7.5% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-28 | Truist Securities | Maintains | Buy | $270 → $290 |
| 2026-07-28 | Baird | Maintains | Neutral | $210 → $280 |
| 2026-07-28 | Guggenheim | Maintains | Buy | $242 → $283 |
| 2026-07-27 | UBS | Maintains | Buy | $288 → $308 |
| 2026-07-27 | TD Cowen | Maintains | Buy | $233 → $263 |
| 2026-07-27 | Morgan Stanley | Maintains | Overweight | $254 → $274 |
| 2026-07-27 | RBC Capital | Maintains | Outperform | $236 → $283 |
| 2026-07-24 | Barclays | Maintains | Overweight | $240 → $271 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 80 — overbought territory; the recent run-up may be due for a pause.
- Price vs 50-day MA: Trading 40.1% above the 50-day MA ($187.50).
- Price vs 200-day MA: Trading 31.8% above the 200-day MA ($199.28).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+5.22) — short-term momentum is improving.
- 52-week range: Price is within 5% of the 52-week high ($262.63).
THC Price Chart
Loading chart for THC…
Fundamentals
About Tenet Healthcare Corporation
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$93B -10.1% YTD
DVA
DaVita Inc.
$15B 110.8% YTD
FMS
Fresenius Medical Care AG
$13B 8.1% YTD
EHC
Encompass Health Corporation
$12B 9.9% YTD
ENSG
The Ensign Group, Inc.
$11B 5.2% YTD
UHS
Universal Health Services, Inc.
$10B -23.6% YTD
CHE
Chemed Corp
$7B 21.3% YTD
PACS
PACS Group, Inc.
$7B 22.3% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.